The classifier could help to flag patients who are most likely to have familial hypercholesterolemia, so that they and their families can undergo further genetic testing.
Seqster’s platform includes data incorporated from 1,000+ healthcare providers comprising 2,000+ hospitals and clinics nationwide
Known as Summix, the method adjusts information to match the ancestry of a person or sample of people with the goal of making large genetic databases more useful for people of traditionally underrepresented ancestries.
Researchers say tool is more accurate at predicting ovarian cancer prognosis than current methods and pinpoints more effective treatments
Upon closing of the transaction, expected in the second quarter, CM Life Sciences will be renamed and its stock listed on Nasdaq global exchange. The deal values Sema4 at $2 billion.
Researchers will launch the study involving 1,000 subjects—consisting of COVID-19 patients and their partners and first-degree relatives as controls—to compare a variety of genomic and other biological variables between those patients who show no or mild symptoms and those who show severe illness.
Precision cancer care company Syapse has announced it has entered a strategic alliance with pharmaceutical company Pfizer that will use real-world evidence to help...
While sequencing entire human genomes is an important achievement of next-generation sequencing (NGS) technology, many clinical research goals can be achieved by sequencing a...
The tool's in-depth analysis of RNA molecules will provide better information of the connections between mutant genetic material and disease
The company's stated goal is to create an environment "where every healthcare decision is optimized by genomics."